RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

An important outbreak of human Q fever in a Swiss Alpine valley.

We describe an important Q fever human epidemic involving 415 serologically confirmed cases in the Val de Bagnes (Valais, Switzerland) during the autumn of 1983. The ages of the 415 cases with acute Q fever ranged from 8 to 82 years with a mean of 35 years, of whom 58% (240) were men and 42% (175) were women. This outbreak started about three weeks after 12 flocks of sheep (between 850 and 900 animals) descended from the alpine pastures to the valley. Geographically, the epidemic reached all the villages in the lower part of the Val de Bagnes located along the road followed by the sheep. As a result, 21.1% of the population of these villages contracted Q fever during this period. In contrast (p less than 0.001), the inhabitants of the higher villages away from the road followed by the sheep were only slightly affected (2.9%). Better collaboration between physicians and veterinarians would prevent such outbreaks in the future.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app